Shares of Nuformix plc (LON:NFX – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.16 ($0.00), with a volume of 198199 shares trading hands. The stock had previously closed at GBX 0.17 ($0.00).
Nuformix Price Performance
The business’s 50-day simple moving average is GBX 0.19 and its 200-day simple moving average is GBX 0.25. The stock has a market cap of £1.39 million, a PE ratio of -1.63 and a beta of 0.28. The company has a quick ratio of 3.35, a current ratio of 1.51 and a debt-to-equity ratio of 1.17.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Further Reading
- Five stocks we like better than Nuformix
- What Are Dividends? Buy the Best Dividend Stocks
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How Can Investors Benefit From After-Hours Trading
- MarketBeat Week in Review – 6/24 – 6/28
- What is a Bond Market Holiday? How to Invest and Trade
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
